(s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist

Details (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist

A - Human Necessities

61

K

A61K 31/135 (2006.01) A61P 25/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2547820

The invention relates to a medicament containing (S)-2-N-propylamino-5- hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N- propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.

L'invention concerne un produit pharmaceutique contenant de la (S)-2-N-propylamino-5-hydroxytétraline, ses sels ou promédicaments. La (S)-2-N-propylamino-5-hydroxytétraline est appropriée comme principe actif ayant un effet agoniste sur le récepteur D3, notamment pour la thérapie de troubles moteurs dopa-sensibles.

Affiliated with

Also associated with

Rating

(s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1698175